Illumina Appeals FTC's Order to Divest Grail, Cites Government Overreach
In its petitioner's brief, Illumina and Grail called the FTC an "unconstitutional agency" and ask the court to revers the commission's decision.
Jury Awards Natera $19.4M in Damages in Invitae, ArcherDx Patent Infringement Suit
A jury determined that Invitae and ArcherDx have infringed three patents and awarded Natera damages for lost profits and past royalties.
Illumina, Ravgen Settle Patent Lawsuit Over NIPTs
The agreement follows settlements that Ravgen has reached with Labcorp, Quest, and PerkinElmer on allegations they infringed Ravgen's patents.
Ravgen NIPT Patents Withstand Illumina Challenge
The US Patent Trial and Appeal Board delivered a pair of rulings stating that Illumina failed to show Ravgen's innovations should be considered unpatentable.
Proove Biosciences CEO Exonerated in PGx Test Kickback Case
Proove's founder and CEO was indicted last year on charges the company had defrauded Medicare and violated the Anti-Kickback Statute by paying physicians to use its pharmacogenetic tests.